FOXM1 and cancer: Furthermore, cell-penetrating ARF26-44 peptide [24] derived from tumor suppressor protein p19ARF and 9R-P201 peptide [25] selected from a random dodecapeptide library against FOXM1 DBD can inhibit FOXM1 transcriptional activities in cancer cells.